Collaborating for What’s Now & What’s Next: Symvivo

01/21/2021
JPM_Symvivo

Collaborating for What’s Now & What’s Next: Symvivo

Progress in Symvivo’s research collaboration with J&J is an important piece in the development and validation of the bacTRL platform and provides value across all of Symvivo’s internal programs.

Related video

Related videos

Collaborating for What’s Now & What’s Next: 1859

Related article

Related articles

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Full article

Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement

Full article